RHY 8.57% 6.4¢ rhythm biosciences limited

News: RHY Rhythm Biosciences Says Clinical Trial Approved By Central Adelaide Local Health Network

  1. 68,051 Posts.
    lightbulb Created with Sketch. 460

    Feb 8 (Reuters) - Rhythm Biosciences Ltd (RHY) :

    • SAYS 1,000-PATIENT PIVOTAL STUDY 7 CLINICAL TRIAL APPROVED BY CENTRAL ADELAIDE LOCAL HEALTH NETWORK
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.